单位:[1]Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China.[2]Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.[3]School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, P.R. China.[4]The First People's Hospital of Lianyungang, the First Affiliated Hospital of Kangda College of Nanjing Medical University. 7 Zhenhua Road, Haizhou, Lianyungang, 222061, Jiangsu, PR China.[5]General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, P.R. China.[6]Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.[7]Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.肿瘤科华中科技大学同济医学院附属同济医院[8]Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China.
This study was supported by the National
Natural Science Foundation of China (82273167, 82104174, 81602626, 12271068,
82172558 and 82373112), Jiangsu Province Basic Research Program Natural Science
Foundation (Outstanding Youth Fund Project, BK20220063), the Key Program of Basic
Science (Natural Science) of Jiangsu Province (22KJA350001), “Huaguo Mountain
Talent Plan” of Lianyungang City (Innovative Talents Liu Bin), Qing Lan Project of
Jiangsu Universities (Outstanding young backbone teachers, Ji Jing), the Natural
Science Foundation of Jiangsu Higher Education Institutions of China (No.
20KJB350008), Priority Academic Program Development of Jiangsu Higher Education
Institutions, College Students’ Innovative Entrepreneurial Training Plan Program
(project Nos. SY202211641640011, SY202311641640002 and SZ202311641640002),
Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei
Province (project Nos. CXPJJH123003-027), the Distinguished Young Scholars of
Nanjing (JQX20008) and Scientific Research Foundation for Returned Scholars of
Tongji Hospital (project 2022hgry021).
第一作者单位:[1]Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China.[2]Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.[3]School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, P.R. China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Ji Jing,Jing Aixin,Ding Yuanyuan,et al.FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression[J].CELL DEATH & DISEASE.2024,15(1):33.doi:10.1038/s41419-024-06421-2.
APA:
Ji Jing,Jing Aixin,Ding Yuanyuan,Ma Xinhui,Qian Qilan...&Liu Bin.(2024).FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression.CELL DEATH & DISEASE,15,(1)
MLA:
Ji Jing,et al."FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression".CELL DEATH & DISEASE 15..1(2024):33